PGT Appoints New VP of Business Development

May 25, 2009

Population Genetics Technologies (PGT) Ltd today announced the appointment of Dr Frank Massam as Vice President of Business Development. The move follows the recent announcement of a £2,000,000 second tranche of Series A funding to further develop and commercialize PGT’s suite of proprietary technologies. Read more

Posted by Mel Kronick | Filed Under Press releases | Comments Off 

PGT Secures Final £2,000,000 of Series A Funding

May 20, 2009

Population Genetics technologies (PGT) Ltd, a privately owned company based in Cambridge, UK today announced that it had successfully met the commercial and development milestones set by its principal investors thereby securing its final £2,000,000 of Series A funding. Read more

Posted by Mel Kronick | Filed Under Press releases | Comments Off 

“Our technology enables the rapid discovery of gene variants characteristic of a particular disorder or a specific drug response."

Dr. Sydney Brenner – Nobel Laureate and co-founder of Population Genetics Technologies Ltd

Read more.

PGT Awarded NHS Grant to Fund Pharmacogenetic Study

PGT has been awarded a grant from the National Institute for Health Research (NIHR) as part of the Institute’s Invention for Innovation (i4i) Programme.

Read More.

Latest News